|
|
||||||||



*
Partners AIDS Research Center and Infectious Disease Division, and
Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129;
AIDS Research Center, First Affiliated Hospital China Medical University, Shenyang, China;
Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom;
¶ Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, MA 02115; and
||
Fenway Community Health Center, Boston, MA 02116
The HIV-1 accessory proteins Vpr, Vpu, and Vif are essential for
viral replication, and their cytoplasmic production suggests that they
should be processed for recognition by CTLs. However, the extent to
which these proteins are targeted in natural infection, as well as
precise CTL epitopes within them, remains to be defined. In this study,
CTL responses against HIV-1 Vpr, Vpu, and Vif were analyzed in 60
HIV-1-infected individuals and 10 HIV-1-negative controls using
overlapping peptides spanning the entire proteins. Peptide-specific
IFN-
production was measured by ELISPOT assay and flow-based
intracellular cytokine quantification. HLA class I restriction and
cytotoxic activity were confirmed after isolation of peptide-specific
CD8+ T cell lines. CD8+ T cell responses
against Vpr, Vpu, and Vif were found in 45%, 2%, and 33% of
HIV-1-infected individuals, respectively. Multiple CTL epitopes were
identified in functionally important regions of HIV-1 Vpr and Vif.
Moreover, in infected individuals in whom the breadth of HIV-1-specific
responses was assessed comprehensively, Vpr and p17 were the most
preferentially targeted proteins per unit length by CD8+ T
cells. These data indicate that despite the small size of these
proteins Vif and Vpr are frequently targeted by CTL in natural HIV-1
infection and contribute importantly to the total HIV-1-specific
CD8+ T cell responses. These findings will be important in
evaluating the specificity and breadth of immune responses during acute
and chronic infection, and in the design and testing of candidate HIV
vaccines.
This article has been cited by other articles:
![]() |
H. Streeck, M. Lichterfeld, G. Alter, A. Meier, N. Teigen, B. Yassine-Diab, H. K. Sidhu, S. Little, A. Kelleher, J.-P. Routy, et al. Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles J. Virol., July 15, 2007; 81(14): 7725 - 7731. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bhattacharya, M. Daniels, D. Heckerman, B. Foley, N. Frahm, C. Kadie, J. Carlson, K. Yusim, B. McMahon, B. Gaschen, et al. Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations Science, March 16, 2007; 315(5818): 1583 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Draenert, T. M. Allen, Y. Liu, T. Wrin, C. Chappey, C. L. Verrill, G. Sirera, R. L. Eldridge, M. P. Lahaie, L. Ruiz, et al. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus J. Exp. Med., March 20, 2006; 203(3): 529 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, B. Metcalf, R. M. Ribeiro, H. McClure, and A. Kaur Th-1-Type Cytotoxic CD8+ T-Lymphocyte Responses to Simian Immunodeficiency Virus (SIV) Are a Consistent Feature of Natural SIV Infection in Sooty Mangabeys J. Virol., March 15, 2006; 80(6): 2771 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Allen, M. Altfeld, S. C. Geer, E. T. Kalife, C. Moore, K. M. O'Sullivan, I. DeSouza, M. E. Feeney, R. L. Eldridge, E. L. Maier, et al. Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution J. Virol., November 1, 2005; 79(21): 13239 - 13249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lichterfeld, D. E. Kaufmann, X. G. Yu, S. K. Mui, M. M. Addo, M. N. Johnston, D. Cohen, G. K. Robbins, E. Pae, G. Alter, et al. Loss of HIV-1-specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1-specific CD4+ T Cells J. Exp. Med., September 20, 2004; 200(6): 701 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lichterfeld, X. G. Yu, M. T. Waring, S. K. Mui, M. N. Johnston, D. Cohen, M. M. Addo, J. Zaunders, G. Alter, E. Pae, et al. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-{gamma} and tumor necrosis factor-{alpha} Blood, July 15, 2004; 104(2): 487 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Allen, M. Altfeld, X. G. Yu, K. M. O'Sullivan, M. Lichterfeld, S. Le Gall, M. John, B. R. Mothe, P. K. Lee, E. T. Kalife, et al. Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection J. Virol., July 1, 2004; 78(13): 7069 - 7078. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cardinaud, A. Moris, M. Fevrier, P.-S. Rohrlich, L. Weiss, P. Langlade-Demoyen, F. A. Lemonnier, O. Schwartz, and A. Habel Identification of Cryptic MHC I-restricted Epitopes Encoded by HIV-1 Alternative Reading Frames J. Exp. Med., April 19, 2004; 199(8): 1053 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Draenert, C. L. Verrill, Y. Tang, T. M. Allen, A. G. Wurcel, M. Boczanowski, A. Lechner, A. Y. Kim, T. Suscovich, N. V. Brown, et al. Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection J. Virol., January 15, 2004; 78(2): 630 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ali, S. Pillai, H. Ng, R. Lubong, D. D. Richman, B. D. Jamieson, Y. Ding, M. J. McElrath, J. C. Guatelli, and O. O. Yang Broadly Increased Sensitivity to Cytotoxic T Lymphocytes Resulting from Nef Epitope Escape Mutations J. Immunol., October 15, 2003; 171(8): 3999 - 4005. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Corbet, H. V. Nielsen, L. Vinner, S. Lauemoller, D. Therrien, S. Tang, G. Kronborg, L. Mathiesen, P. Chaplin, S. Brunak, et al. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes J. Gen. Virol., September 1, 2003; 84(9): 2409 - 2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Altfeld, M. M. Addo, R. Shankarappa, P. K. Lee, T. M. Allen, X. G. Yu, A. Rathod, J. Harlow, K. O'Sullivan, M. N. Johnston, et al. Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences J. Virol., July 1, 2003; 77(13): 7330 - 7340. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meyer-Olson, K. W. Brady, J. T. Blackard, T. M. Allen, S. Islam, N. H. Shoukry, K. Hartman, C. M. Walker, and S. A. Kalams Analysis of the TCR {beta} Variable Gene Repertoire in Chimpanzees: Identification of Functional Homologs to Human Pseudogenes J. Immunol., April 15, 2003; 170(8): 4161 - 4169. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Addo, X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al. Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load J. Virol., February 1, 2003; 77(3): 2081 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Novitsky, H. Cao, N. Rybak, P. Gilbert, M. F. McLane, S. Gaolekwe, T. Peter, I. Thior, T. Ndung'u, R. Marlink, et al. Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C J. Virol., September 11, 2002; 76(20): 10155 - 10168. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. G. Yu, M. M. Addo, E. S. Rosenberg, W. R. Rodriguez, P. K. Lee, C. A. Fitzpatrick, M. N. Johnston, D. Strick, P. J. R. Goulder, B. D. Walker, et al. Consistent Patterns in the Development and Immunodominance of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T-Cell Responses following Acute HIV-1 Infection J. Virol., July 29, 2002; 76(17): 8690 - 8701. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yusim, C. Kesmir, B. Gaschen, M. M. Addo, M. Altfeld, S. Brunak, A. Chigaev, V. Detours, and B. T. Korber Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation J. Virol., July 29, 2002; 76(17): 8757 - 8768. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Lauer, K. Ouchi, R. T. Chung, T. N. Nguyen, C. L. Day, D. R. Purkis, M. Reiser, A. Y. Kim, M. Lucas, P. Klenerman, et al. Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities J. Virol., May 13, 2002; 76(12): 6104 - 6113. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |